07:00 , Sep 1, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: CD1A; interleukin-17 (IL-17); IL-22

Dermatology INDICATION: Dermatitis; psoriasis Mouse and patient sample studies suggest inhibiting CD1A could help treat dermatitis, psoriasis and other inflammatory skin diseases. In a mouse model of poison ivy-induced dermatitis, transgenic expression of human CD1A...
07:00 , Aug 7, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Infectious Disease Tuberculosis Group I CD1 isoforms (CD1a, CD1b and CD1c) A study in cell culture suggests that lipid antigens that...